期刊
CELL METABOLISM
卷 28, 期 1, 页码 1-2出版社
CELL PRESS
DOI: 10.1016/j.cmet.2018.06.015
关键词
-
资金
- Medical Research Council (MRC Metabolic Diseases Unit) [MRC_MC_UU_12012/1]
- MRC [MC_UU_12012/5, MC_UU_12012/1] Funding Source: UKRI
Safe and effective pharmacological treatments for severe obesity remain scarce. In this issue of Cell Metabolism, Iepsen et al. (2018) show that obese patients with pathogenic melanocortin 4 receptor mutations, the most common form of monogenic obesity, lose weight with glucagon-like peptide 1 (GLP-1) receptor agonist therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据